ST
CLVS

Spot Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Spot Trading’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,900
Closed -$26K – 3655
2016
Q2 		$26K Buy
+1,900
New +$27.8K ﹤0.01% 2932
2015
Q4 		– Sell
-400
Closed -$37K – 4200
2015
Q3 		$37K Sell
400
-2,200
-85% -$190K ﹤0.01% 3355
2015
Q2 		$228K Sell
2,600
-3,800
-59% -$325K ﹤0.01% 2631
2015
Q1 		$475K Buy
6,400
+3,100
+94% +$219K ﹤0.01% 2144
2014
Q4 		$185K Buy
3,300
+300
+10% +$15.8K ﹤0.01% 2965
2014
Q3 		$136K Buy
+3,000
New +$125K ﹤0.01% 3377

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return